Polymeric capsules

By forming small droplets of dispersed phase on a membrane and initiating polymer precursor polymerization, capsules with narrow size distribution and uniform burst strength are prepared, solving the problem of uneven capsule size and strength in the prior art. This achieves the stability and controlled release of beneficial agents, and improves the product's shelf life and efficiency.

CN122399696APending Publication Date: 2026-07-17PROCTER & GAMBLE CO
View PDF 3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
PROCTER & GAMBLE CO
Filing Date
2020-04-17
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing technologies struggle to achieve stability and controlled release of active ingredients during encapsulation, especially in maintaining the integrity of active substances throughout the supply chain. Furthermore, uneven distribution of capsule size and rupture strength affects product shelf life and efficiency.

Method used

By forming small droplets of dispersed phase on the second side of the membrane and initiating polymer precursor polymerization in the continuous phase, a capsule with a polymer shell surrounding the core is formed. This controls the size distribution and rupture strength of the capsule, ensuring the stability and release control of the beneficial agent within the capsule.

Benefits of technology

This achieves a narrow size distribution and uniform burst strength in the capsules, ensuring the uniform release of beneficial agents in the formulated product, improving product stability and efficiency, reducing the use of non-functional materials, and lowering costs and environmental impact.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122399696A_ABST
    Figure CN122399696A_ABST
Patent Text Reader

Abstract

本发明涉及聚合物胶囊,具体公开了一种胶囊群体,其可包括多个胶囊,该胶囊可包括包含有益剂的芯和包围芯的聚合物壳。胶囊群体可具有约15%至约230%的Δ破裂强度百分比以及约20nm至约400nm的壳厚度。
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Delivery particle

    US20110268802A1

  • Hydrophilic liquid encapsulates

    WO2011084141A2

  • Benefit agent containing delivery particle slurries

    WO2018169531A1